Trial Profile
Dexmedetomidine versus midazolam for sedation of pediatric intensive care patients at Oslo University.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 25 Nov 2016
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary) ; Midazolam
- Indications Neurological disorders
- Focus Adverse reactions; Therapeutic Use
- Acronyms DEX-studie
- 25 Nov 2016 New trial record